For more than two decades, Chan Soon-Shiong Institute of Molecular Medicine at Windber has kept a mission to improve patients’ care through research. That mission is now expanding to ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

The new drug uses a so-called cloaking device and only activates when it reaches the tumour ...

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

New research breaks it down.

At the 2026 Genitourinary Cancers Symposium in San Francisco, CA, Madan discusses a study investigating short-course (3-month ...

New research suggests that a vegetarian diet can help lower the risk of cancer, but not in all cases. We spoke to experts to ...

A new drug for advanced prostate cancer has shown promise in early trials experts have said, with the medication shrinking tumors in some patients. Prostate cancer is the most common cancer among men ...

Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...